Literature DB >> 16545484

Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells.

Kazuhito Naka1, Ken-ichi Abe, Kazunori Takemoto, Hiromichi Dansako, Masanori Ikeda, Kunitada Shimotohno, Nobuyuki Kato.   

Abstract

BACKGROUND/AIMS: We previously established hepatitis C virus (HCV) replicon-harboring cell lines possessing two interferon (IFN)-resistant phenotypes: a partially resistant phenotype (alphaR series) and a severely resistant phenotype (betaR series). We recently found that the severe IFN resistance of the betaR-series cells is caused by the functional disruption of type I IFN receptors. Here, we aimed to clarify the mechanism(s) underlying the partial IFN resistance of the alphaR-series cells.
METHODS: alphaR-series cells were pre-treated with 5-azacytidine to evaluate the effects of DNA demethylation on IFN resistance. cDNA microarray analysis was carried out in order to compare 1alphaR cells, which belong to the alphaR series, treated with both 5-azacytidine and IFN-alpha with cells treated with 5-azacytidine or IFN-alpha alone.
RESULTS: We found that the IFN-resistant phenotype of alphaR-series cells was impaired by treatment with 5-azacytidine. cDNA microarray analysis identified seven IFN-stimulated genes, which were up-regulated by 5-azacytidine treatment. We demonstrated here that the ectopic expression of each of these seven genes in 1alphaR cells frequently weakened the IFN resistance of these cells.
CONCLUSIONS: The present results suggest that the epigenetic silencing of IFN-stimulated genes is implicated in the acquisition of a partially IFN-resistant phenotype of HCV replicon-harboring cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545484     DOI: 10.1016/j.jhep.2006.01.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Epigenetic silencing of antiviral genes renders clones of Huh-7 cells permissive for hepatitis C virus replication.

Authors:  Qiuyue Chen; Bray Denard; Hua Huang; Jin Ye
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

2.  Epigenetic Suppression of Interferon Lambda Receptor Expression Leads to Enhanced Human Norovirus Replication In Vitro.

Authors:  Sabastine E Arthur; Frédéric Sorgeloos; Myra Hosmillo; Ian G Goodfellow
Journal:  mBio       Date:  2019-10-01       Impact factor: 7.867

3.  Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus.

Authors:  John Paul Pezacki; Selena M Sagan; Angela M Tonary; Yanouchka Rouleau; Sylvie Bélanger; Lubica Supekova; Andrew I Su
Journal:  BMC Chem Biol       Date:  2009-01-16

Review 4.  Exploiting tumor epigenetics to improve oncolytic virotherapy.

Authors:  Nicole E Forbes; Hesham Abdelbary; Mathieu Lupien; John C Bell; Jean-Simon Diallo
Journal:  Front Genet       Date:  2013-09-20       Impact factor: 4.599

Review 5.  Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.

Authors:  Nicole E Forbes; Ramya Krishnan; Jean-Simon Diallo
Journal:  Front Oncol       Date:  2014-07-23       Impact factor: 6.244

Review 6.  Modulation of host metabolism as a target of new antivirals.

Authors:  Masanori Ikeda; Nobuyuki Kato
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.